SaniSure, a global developer and manufacturer of single-use technology for the biopharmaceutical industry, has acquired GL Engineering (GLE) of East Hanover, NJ.  With this acquisition, SaniSure will expand its global integrated offering of drug product fill and finish bioprocessing assemblies and solution including:
 
• Adding new capabilities and manufacturing capacities for drug product filling needles and assemblies.
• GLE will become the center of excellence for the development of drug product filling solutions.
• Extension of the SaniSure sterile manufacturing platform with a strong focus on final filling.
 
The acquisition complements each company's technical capabilities, product offering and commercial reach. SaniSure has a direct sales force in the U.S. and Europe together with strategic regional distributors and manufacturer representatives. GLE is a leader in filling needle design and manufacturing.
 
"We are very excited about the addition of GLE to our innovative product portfolio," said Thomas J. Hook, CEO, SaniSure. "GLE's high-quality, global standards filling needle line represents an important expansion to SaniSure's customer-focused solutions. Drug product filling solutions are a critical step in many of our customers' processes. Having the ability to vertically integrate GLE's solutions is quite unique.”
 
Global demand for single-use technology is increasing rapidly with increasing R&D activities, a high level of biotech investments and strong global markets fueling a double-digit market growth rate.
 
Gerhard Liepold, founder, GL Engineering, said, "SaniSure's assembly capabilities and commercial reach will significantly enhance the commercialization of our unique single-use needle design," said GL Engineering Founder Gerhard Liepold. “We are very proud to join the SaniSure team and bring more than two decades of pharmaceutical industry experience with strong engineering and commitment to design innovation in the single-use market."
 
Liepold will now join SaniSure as the global product manager for drug product filling solutions